세계의 항비만약 시장

Highlights:

This report provides an overview of the global market on anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection. The report details the anti-obesity drugs market based on drug type, distribution channel, and region.

Report Scope:

The report's scope includes an overview of the global market for anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.

The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading market players' profiles, marketed products, pipeline products, and recent market activities are provided. The report details market for anti-obesity drugs based on drug type, distribution channel, and region. Based on drug type, the market is segmented into prescription drugs, and over-the-counter (OTC) drugs. The market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies on the basis of distribution channel. Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).

Report Includes:

• An overview of the current and future global markets for anti-obesity drugs
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimate of the actual market size and revenue forecast for the global anti-obesity drugs market, and corresponding market share analysis based on drug type, distribution channel, and region
• Overview of ESG outlook with emphasis on sustainability trends and factors on anti-obesity drugs market
• Identification of the major vendors in the global market for anti-obesity drugs, along with an analysis of the structure of this industry, including company market shares, M&A deals and venture fundings
• Profiles of the leading global players

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Research Methodology
• Information Sources
• Geographic Breakdown
• Segmentation Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market Overview

• Definitions of Adult Obesity and Overweight
• Overweight- and Obesity-Related Diseases
• Rising Prevalence of Obesity
• Impact of Obesity on Global Economy
• Increasing Awareness Regarding Obesity
• SWOT Analysis
• Strengths
• Weaknesses
• Opportunities
• Threats

Chapter 4 Global Market for Anti-obesity Drugs by Type

• Prescription Drugs
• Over-the-Counter Anti-obesity Drugs

Chapter 5 Global Market for Anti-obesity Drugs by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Chapter 6 Global Market for Anti-obesity Drugs by Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 ESG Developments

• Introduction to ESG
• Importance of ESG in Anti-obesity Drugs Industry
• ESG Pillars in the Anti-obesity Drug Industry
• Environmental Metrics
• Social Metrics
• Governance Metrics
• ESG Ratings and Metrics: Understanding the Data
• ESG Practices in the Anti-obesity Drug Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 8 Competitive Landscape

• Overview
• Pipeline Analysis
• Patents on Obesity Management, 2020-2023

Chapter 9 Company Profiles

• ALTIMMUNE INC.
• BOEHRINGER INGELHEIM INTERNATIONAL GMBH
• CURRAX PHARMACEUTICALS LLC
• ELI LILLY AND CO.
• F. HOFFMANN-LA ROCHE AG
• GLAXOSMITHKLINE PLC
• NOVO NORDISK A/S
• PFIZER INC.
• RHYTHM PHARMACEUTICALS, INC.
• VIVUS LLC